Cryo Cell International Inc
CCEL- Exchange
- NYSE
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0000862692
No open-market purchases or sales by Cryo Cell International Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $1.77M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Cryo Cell International Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 3 | 10 | +7 |
| Shares | 144.8K | 650.7K | +505.9K (+349.3%) |
| Value | $1.30M | $7.88M | +$6.58M (+506.7%) |
New holders (8)
Institutions that held Cryo Cell International Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Iszo Capital Management LP | 496,503 | $6.01M | 2.65% |
| Maryland Capital Management | 19,563 | $237.0K | 0.01% |
| HighTower Advisors, LLC | 12,761 | $155.0K | 0.00% |
| Bank of America Corp | 1,000 | $12.0K | 0.00% |
| Morgan Stanley | 700 | $8.00K | 0.00% |
| Wells Fargo & Company | 500 | $6.00K | 0.00% |
| UBS Group AG | 152 | $2.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 7 | $0 | 0.00% |
Sold out (1)
Institutions that held Cryo Cell International Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Legato Capital Management LLC | 23,189 | $208.0K |